Achieving Ultrafast Liquid Chromatography - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Achieving Ultrafast Liquid Chromatography
The authors review methods for reducing analysis time and increasing throughput that are reliable and maintain data integrity.

Pharmaceutical Technology

Many applications, however, can be accomplished with a single, well-engineered, component-based HPLC system. To limit oneself to a highly restrictive system in today's ever-changing laboratory environment is not ideal. One may need to add different detectors to the system to accomplish a new task or one may add switching valves to increase throughput even more. A modular system that is based on sound engineering principles includes pumping options that deliver a wide flow-rate range with precise delivery resolution, incorporates an accurate and precise autosampler that provides excellent carryover performance, and has the accessories necessary for continued expansion offers superior performance for UFLC and traditional HPLC.


One can address the problem of increased system pressure that results from very small particle-size columns by choosing a well-packed mid-size particle material instead. These mid-size columns offer similar performance, yet generate less than half of the back pressure compared with commercially available sub-2-μm particle columns. Coupling these mid-size particle columns with good chromatographic techniques and a well-engineered high-performance liquid chromatography system enables users to shorten analysis time drastically, without the consequence of extreme pressures. The right columns and techniques also permit users to maintain high separation efficiency and fulfill system-performance needs such as reproducibility, reduced carryover, and durability. The end result is high-quality data obtained without compromises.

The goal of fast liquid chromatography is not high pressure; high pressure is simply a consequence of using a column packed with a small particle (sub 2 μm). The goal is increased throughput (i.e., analyzing more samples per day, per hour or per minute). To achieve high throughput, the run time of a single chromatogram must be optimized, and the total cycle time of the assay must be examined and optimized as well. After all, what good is a 30-s separation if it takes 45 s to inject the next sample?

Curtis R. Campbell, PhD*, is a high-performance liquid chromatography (HPLC) product manager, and Susan Steinike is an HPLC senior product specialist at Shimadzu Scientific Instruments, 7102 Riverwood Dr., Columbia, MD 21046, tel. 800.477.1227,

*To whom all correspondence should be addressed.


1. Butchart, et al., "Do Sub 2 μm Particles Offer the Best Performance for Short Fast Gradients?" in poster session presented at the 31st International Symposium on High Performance Liquid Phase Separations and Related Techniques (Ghent, Belgium, June 17–21, 2007)


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here